Status:
COMPLETED
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of the study is to investigate the effect of Victoza (a GLP-1 receptor agonist)on insulin-dose, risk of hypoglycemia and gastric emptying rate during hypoglycemia in patients with type 1 diabe...
Eligibility Criteria
Inclusion
- age 18-50y,
- BMI 18-27,
- caucasian origin,
- type 1 diabetes diagnosed between age 5 and age 40,
- no known diabetes complications or cardiovascular diseases,
- no medication known to influence glucose homeostasis,
- no pregnancy
Exclusion
- diabetes complications,
- autonomous nerve dysfunction,
- anaemia,
- HbA1c \< 8.5% at screening,
- estimated by the investigator to be incapable of completing the trial.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00993720
Start Date
October 1 2009
End Date
October 1 2010
Last Update
January 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre University Hospital
Hvidovre, Denmark, 2650